May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Prolonged Gene Expression in Non–Human Primate Retina Using Recombinant Sivagm–Based Lentiviral Vectors
Author Affiliations & Notes
  • Y. Ikeda
    Kyushu University, Fukuoka, Japan
    Dept of Ophthalmology,
  • Y. Yonemitsu
    Kyushu University, Fukuoka, Japan
    Dept of Pathology,
  • M. Miyazaki
    Kyushu University, Fukuoka, Japan
    Dept of Ophthalmology,
  • R.–I. Kohno
    Kyushu University, Fukuoka, Japan
    Dept of Ophthalmology,
    Dept of Pathology,
  • T. Murata
    Dept of Ophthalmology, Shinshu University, Matsumoto–city, Japan
  • Y. Goto
    International University of Health and Welfare, Ohkawa–city, Japan
  • K. Terao
    Tsukuba Primate Center, Tsukuba–city, Japan
  • M. Hasegawa
    DNAVEC Research Inc., Tsukuba–city, Japan
  • K. Sueishi
    Kyushu University, Fukuoka, Japan
    Dept of Pathology,
  • T. Ishibashi
    Kyushu University, Fukuoka, Japan
    Dept of Ophthalmology,
  • Footnotes
    Commercial Relationships  Y. Ikeda, None; Y. Yonemitsu, None; M. Miyazaki, None; R. Kohno, None; T. Murata, None; Y. Goto, None; K. Terao, None; M. Hasegawa, DNAVEC Research Inc., E; K. Sueishi, None; T. Ishibashi, None.
  • Footnotes
    Support  a Grant of Promotion of Basic Science Research in Medical Frontier of the Organization for Pharmaceutical Safety and Research
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5792. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Ikeda, Y. Yonemitsu, M. Miyazaki, R.–I. Kohno, T. Murata, Y. Goto, K. Terao, M. Hasegawa, K. Sueishi, T. Ishibashi; Prolonged Gene Expression in Non–Human Primate Retina Using Recombinant Sivagm–Based Lentiviral Vectors . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5792.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Previously, we reported the simian immunodeficiency virus from African green monkey (SIVagm)–mediated efficient gene transfer and therapeutic effects for retinal degeneration in rodents. We now make arrangements for a clinical application to treat retinitis pigmentosa. Thus, it is important to evaluate exactly the efficiency and safety issues for a gene transfer vector itself using large animals. In this study, we have evaluated the ability of our 3rd generation SIVagm vectors to transfer genes into non–human primate retinas as a preclinical study.

Methods: : Five Macaca fascicularis were enrolled in this study. Approximately 20 µl of SIV–GFP (green fluorescent protein) (low titer: 2.5x107 transducing units [TU]/ml, equal to clinically available titer, n=2) or SIV–hPEDF (human pigment epithelium–derived factor) (low titer, high titer: 2.5x108 TU/ml, and max titer: 1.0x109 TU/ml, n=1, respectively) were injected into subretinal space via a glass capillary tube. To detect GFP expression in the retina, we used a fluorescence fundus camera at various time–points after gene transfer (days 14, 28, 90, 180, 270, 360, and 540). Human PEDF expression was assessed with the immunohistochemical analysis for the retinal tissue treated with SIV–hPEDF on day 50.

Results: : The retinas demonstrated a frequent GFP expression that preserved at least for 540 days without significant decline. In all SIV–hPEDF treated eyes, human PEDF expression was detected in retinal pigment epithelium and the layer of rods and cones of retina. There was no remarkable inflammatory cell infiltration in retinal tissue treated with a max titer of SIV–hPEDF on day 50.

Conclusions: : We thus propose that SIVagm–mediated stable gene transfer might be useful for ocular gene transfer in a clinical setting. We are now conducting the safety study in non–human primates.

Keywords: gene transfer/gene therapy • retinal degenerations: cell biology • retinal pigment epithelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×